Systematic review of gender bias in vortioxetine clinical trials

This paper evaluates gender bias in the published clinical trials of Vortioxetine

María Santos-Casado; Ana Belén Guisado-Gil; Bernardo Santos-Ramos

2020

Scholarcy highlights

  • The proportion of women included was slightly higher than that in clinical trials of other antidepressants
  • Six of the 23 trials analyzed secondary variables separated by sex
  • This paper evaluates gender bias in the published clinical trials of Vortioxetine
  • We conducted a systematic review of controlled clinical trials of Vortioxetine for the treatment of depression
  • 6/23 trials analyzed secondary variables separated by sex
  • This gives rise to gender bias in these works

Need more features? Save interactive summary cards to your Scholarcy Library.